Skip to main content
Premium Trial:

Request an Annual Quote

Persistence Capital to Hold Majority Stake in Warnex

NEW YORK (GenomeWeb News) – Warnex said this week that the conversion of debentures into shares of the company will provide Persistence Capital Partners with a nearly 52 percent stake in the firm.

The conversion of C$725,000 in principal amount of debentures into an aggregate of 46,178,344 common shares of Warnex was set to take place yesterday.

The Montreal-based private equity firm also has given Warnex until April 13 to repay the remaining balance of approximately C$959,420 owed under the debentures. Warnex is currently working on putting in place a C$2 million credit facility, which would provide it with funds to repay the outstanding balance of the debentures.

Laval, Quebec-based Warnex also reported yesterday that its fiscal-year 2011 revenues declined 4 percent to C$21.3 million from C$22.3 million. The firm, however, posted a profit of C$500,000, or C$.01 per share, compared to a net loss in 2010 of C$1.7 million, or C$.03 per share.

Warnex also said that has named Marc Lebel as its interim CEO.

The firm is currently assessing its strategic alternatives. In February, Warnex said that the planned sale of its Analytical Services division had fallen through "due to the failure of its prospective purchaser to perform its obligations as contemplated by the binding agreement entered into between the parties."

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.